Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results